A leader in research, Stony Brook's Division of Pediatric Infectious Diseases oversees a growing clinical study population. National pediatric clinical trials conducted on site include studies of novel vaccines, antibiotics and antivirals for children with severe influenza.
For children growing up with HIV, access to clinical research can make a tremendous difference in their quality of life and prognosis. As the Designated AIDS Center (DAC) for Suffolk County, Stony Brook has been heavily involved in studying new therapies and new combinations of therapies to treat HIV since 1985. Pursuing new and better ways to prevent, diagnose and treat HIV-infected children, the Division of Pediatric Infectious Diseases offers 15 to 20 clinical studies of new medications and therapy at any given time. These include trials sponsored by National Institutes of Health (NIH) as well as industry- funded studies. The Division has been a PACTG/IMPAACT funded site since 1992 and is currently offering participation in 11 HIV/AIDS clinical trials, including three that assess H1N1 flu vaccines in HIV-infected women and children.
Faculty members within the Division of Pediatric Infectious Diseases have been published extensively in national medical journals.